XCE Tirzepatide Peptide - High Purity GLP-1 Agonist for Research Use

XCE Tirzepatide is a synthetic peptide compound belonging to the class of GLP-1 receptor agonists. This pharmaceutical grade peptide has shown promising results in research applications related to metabolic regulation and weight management.

The molecular structure of XCE Tirzepatide allows for dual activation of both GLP-1 and GIP receptors, making it particularly effective in research settings. The peptide works by slowing gastric emptying, reducing appetite, and improving insulin sensitivity.

Our XCE Tirzepatide is supplied as a white lyophilized powder with guaranteed high purity levels. The product undergoes rigorous quality control testing including HPLC analysis to ensure consistency between batches.

For research purposes, typical dosing ranges from 2.5mg to 15mg per week, depending on study parameters. The peptide demonstrates excellent stability when stored properly in cool, dry conditions.

XCE Tirzepatide has shown particular promise in studies related to:

- Glucose metabolism regulation
- Appetite suppression mechanisms
- Weight management research
- Metabolic syndrome studies
- Insulin sensitivity improvement

The product is available in various concentrations to accommodate different research protocols and study designs. Custom formulations and packaging options are available for bulk orders.

All our XCE Tirzepatide products are manufactured under strict quality control standards in GMP-compliant facilities. Each batch is accompanied by comprehensive analytical documentation including HPLC chromatograms and mass spectrometry reports.

Note: This product is intended for research use only. Not for human consumption or diagnostic use.